Science & Technology

SCTIMST Unveils 'Chitra Core' Indigenous Low-Metal Coronary Stent

16 August 2026UPSCSSC

In Brief

Develops an advanced indigenous coronary stent designed to significantly reduce restenosis and blood clotting risks.

Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, an autonomous institute under the Department of Science and Technology, has developed an indigenous coronary stent named 'Chitra Core'. The medical device features a patented structural design that uses 30 to 40 per cent less metal than conventional cardiac stents available in the global market, marking a significant advancement in domestic cardiovascular medical technology.

Coronary artery stents are tiny expandable mesh tubes inserted into clogged arteries to restore normal blood flow. Conventional metal stents often pose risks of long-term complications, including in-stent restenosis (re-narrowing of the artery due to tissue overgrowth) and stent thrombosis (formation of dangerous blood clots). SCTIMST engineered the Chitra Core stent to minimize these clinical complications by optimizing strut thickness and improving vessel wall compliance.

Cardiovascular diseases remain the leading cause of mortality in India, driving high demand for affordable angioplasty hardware. By reducing reliance on imported cardiac devices, Chitra Core aligns with the National Medical Devices Policy 2023, which aims to boost self-reliance in high-end medical equipment. Rigorous pre-clinical trials demonstrated superior re-endothelialization rates and structural stability compared to imported cobalt-chromium and platinum-chromium drug-eluting stents.

For civil services aspirants, this development is crucial for GS Paper III (Indigenization of Technology and Public Health). Prelims MCQs frequently cover autonomous research institutes like SCTIMST and biomedical innovations, while Mains questions evaluate India's health technology ecosystem and strategies to reduce out-of-pocket healthcare expenses.

UPSC Study NotesHIGHGS3 — Science & Technology (Indigenization of Technology) & GS2 — Health

GS3 — Science & Technology (Indigenization of Technology) & GS2 — Health

📌 Exam Angle

Prelims can test the institutional affiliation of SCTIMST under DST or medical terms like restenosis and thrombosis. Mains answers can utilize this case study to illustrate domestic medtech advancements under the National Medical Devices Policy 2023 to curb out-of-pocket healthcare expenditure.

⚠️ Key Concerns

India remains heavily dependent on imported raw materials and micro-components for high-end medical device manufacturing. Furthermore, complex regulatory approval delays and weak industry-academia commercialization bridges often prevent domestic innovations from scaling effectively against established global brands.

💡 Why It Matters

With cardiovascular diseases being India's leading cause of mortality, affordable native stents significantly reduce catastrophic health spending for families. It elevates India's high-end precision biomedical engineering capabilities, directly furthering the vision of Atmanirbhar Bharat in critical healthcare.

🔑 Must Remember

• SCTIMST is an autonomous institute under the Department of Science and Technology. • Chitra Core uses 30-40% less metal, significantly lowering restenosis and blood clot risks. • The innovation advances the goals of the National Medical Devices Policy 2023.

📝 Key Terms

SCTIMSTChitra CoreIn-stent RestenosisStent ThrombosisNational Medical Devices Policy 2023Indigenization of TechnologyOut-of-Pocket ExpenditureDrug-Eluting Stents

SCTIMST Unveils 'Chitra Core' Indigenous Low-Metal Coronary Stent

More in Science & Technology